KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q3 2025 value amounting to $14.3 billion.

  • Vertex Pharmaceuticals' Non-Current Assets rose 1492.91% to $14.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $53.7 billion, marking a year-over-year increase of 2536.97%. This contributed to the annual value of $12.9 billion for FY2024, which is 5067.32% up from last year.
  • Per Vertex Pharmaceuticals' latest filing, its Non-Current Assets stood at $14.3 billion for Q3 2025, which was up 1492.91% from $13.6 billion recorded in Q2 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Non-Current Assets ranged from a high of $14.3 billion in Q3 2025 and a low of $3.6 billion during Q1 2021
  • Its 5-year average for Non-Current Assets is $7.8 billion, with a median of $6.5 billion in 2023.
  • Its Non-Current Assets has fluctuated over the past 5 years, first plummeted by 200.28% in 2021, then soared by 7689.44% in 2024.
  • Over the past 5 years, Vertex Pharmaceuticals' Non-Current Assets (Quarter) stood at $3.9 billion in 2021, then increased by 26.97% to $4.9 billion in 2022, then soared by 74.65% to $8.6 billion in 2023, then skyrocketed by 50.67% to $12.9 billion in 2024, then grew by 10.48% to $14.3 billion in 2025.
  • Its Non-Current Assets was $14.3 billion in Q3 2025, compared to $13.6 billion in Q2 2025 and $12.9 billion in Q1 2025.